| # | Country | Total Patents | |
|---|---|---|---|
| #1 | EPO (European Patent Office) | 6 | |
| #2 | WIPO (World Intellectual Property Organization) | 6 | |
| #3 | Canada | 5 | |
| #4 | United States | 5 | |
| #5 | Australia | 2 | |
| #6 | China | 2 | |
| #7 | Brazil | 1 | |
| #8 | Republic of Korea | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Measurement | |
| #4 | Organic fine chemistry |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Peptides | |
| #3 | Medical preparations | |
| #4 | Analysing materials | |
| #5 | Sugars |
| # | Name | Total Patents |
|---|---|---|
| #1 | Lee Gregory | 14 |
| #2 | Lee Chi-Yu Gregory | 12 |
| #3 | Gregory Lee Chi-Yu | 1 |
| #4 | Gregory Lee | 1 |
| Publication | Filing date | Title |
|---|---|---|
| EP3749367A1 | Use of ghr-106 monoclonal antibody as a gnrh antagonist | |
| US2014030253A1 | Humanized forms of monoclonal antibodies to human GnRH receptor | |
| US2013340102A1 | Humanized antibodies to CA215 | |
| EP2593467A1 | Carbohydrate hapten-based anti-cancer vaccines and antibody drugs | |
| CA2780713A1 | Monoclonal antibodies against gonadotropin-releasing hormone receptor | |
| CN102014955A | Carbohydrate-containing pan cancer marker |